Literature DB >> 27407598

Changing Practice of Gynecologic Oncology based on Current Evidence.

Hemant B Tongaonkar1.   

Abstract

Keywords:  Evidence based medicine; Gynaecological oncology; Radiation therapy

Year:  2011        PMID： 27407598      PMCID： PMC4923023          DOI： 10.1016/S0377-1237(04)80095-9

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  28 in total

1.  Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results.

Authors:  J E Sardi; A Giaroli; C Sananes; M Ferreira; A Soderini; A Bermudez; L Snaidas; S Vighi; N Gomez Rueda; G di Paola
Journal:  Gynecol Oncol       Date:  1997-10       Impact factor: 5.482

2.  Staging and therapeutic value of lymphadenectomy in endometrial cancer.

Authors:  K C Podratz; A Mariani; M J Webb
Journal:  Gynecol Oncol       Date:  1998-08       Impact factor: 5.482

3.  Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study.

Authors:  F M Muggia; P S Braly; M F Brady; G Sutton; T H Niemann; S L Lentz; R D Alvarez; P R Kucera; J M Small
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

4.  Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients.

Authors:  E J Junor; D J Hole; L McNulty; M Mason; J Young
Journal:  Br J Obstet Gynaecol       Date:  1999-11

5.  Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results.

Authors:  M J Piccart; K Bertelsen; K James; J Cassidy; C Mangioni; E Simonsen; G Stuart; S Kaye; I Vergote; R Blom; R Grimshaw; R J Atkinson; K D Swenerton; C Trope; M Nardi; J Kaern; S Tumolo; P Timmers; J A Roy; F Lhoas; B Lindvall; M Bacon; A Birt; J E Andersen; B Zee; J Paul; B Baron; S Pecorelli
Journal:  J Natl Cancer Inst       Date:  2000-05-03       Impact factor: 13.506

Review 6.  Complete surgical staging of early endometrial adenocarcinoma: optimizing patient outcomes.

Authors:  M N Barnes; L C Kilgore
Journal:  Semin Radiat Oncol       Date:  2000-01       Impact factor: 5.934

7.  Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix.

Authors:  W A Peters; P Y Liu; R J Barrett; R J Stock; B J Monk; J S Berek; L Souhami; P Grigsby; W Gordon; D S Alberts
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

8.  Dose-tumor response of carcinoma of cervix: an analysis of 594 patients treated by radiotherapy.

Authors:  D Choy; L C Wong; J Sham; H Y Ngan; H K Ma
Journal:  Gynecol Oncol       Date:  1993-06       Impact factor: 5.482

9.  International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.

Authors:  J Baptist Trimbos; Mahesh Parmar; Ignace Vergote; David Guthrie; Giorgio Bolis; Nicoletta Colombo; Jan B Vermorken; Valter Torri; Constantino Mangioni; Sergio Pecorelli; Andrea Lissoni; Ann Marie Swart
Journal:  J Natl Cancer Inst       Date:  2003-01-15       Impact factor: 13.506

Review 10.  First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence.

Authors:  J Sandercock; M K B Parmar; V Torri; W Qian
Journal:  Br J Cancer       Date:  2002-10-07       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.